Obstruktive Schlafapnoe und Nieren

Die fortgeschrittene, aber auch die frühe subklinische chronische Niereninsuffizienz (CNI) verschlechtert unabhängig die renale und kardiovaskuläre Prognose. CNI und obstruktive Schlafapnoe (OSA) sind häufig und kommen deshalb auch oft zufällig gemeinsam vor. Darüber hinaus begünstigen sich die beiden Krankheitsbilder gegenseitig.

• Literatur

• 1 Matsushita K, van der Velde M, Astor BC. et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010; Jun 12; 375 (9731) 2073-2081.
• 2 Shlipak MG, Matsushita K, Arnlov J. et al. Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med 2013; Sep 5; 369 (10) 932-943.
• 3 Klausen K, Borch-Johnsen K, Feldt-Rasmussen B. et al. Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation 2004; Jul 6; 110 (01) 32-35.
• 4 Markou N, Kanakaki M, Myrianthefs P. et al. Sleep-disordered breathing in nondialyzed patients with chronic renal failure. Lung 2006; Jan-Feb 184 (01) 43-49.
• 5 Kimmel PL, Miller G, Mendelson WB. Sleep apnea syndrome in chronic renal disease. Am J Med 1989; Mar; 86 (03) 308-314.
• 6 Jurado Gamez B, Martin-Malo A, Fernandez Marin MC. et al. [Sleep disorders in patients on a kidney transplant waiting list]. Arch Bronconeumol 2008; Jul; 44 (07) 371-375.
• 7 Sim JJ. et al. Sleep apnea in early and advanced chronic kidney disease: Kaiser Permanente Southern California cohort. Chest 2009; Mar; 135 (03) 710-716.
• 8 Beecroft J, Duffin J, Pierratos A. et al. Enhanced chemo-responsiveness in patients with sleep apnoea and end-stage renal disease. Eur Respir J 2006; Jul; 28 (01) 151-158.
• 9 Redolfi S, Yumino D, Ruttanaumpawan P. et al. Relationship between overnight rostral fluid shift and Obstructive Sleep Apnea in nonobese men. Am J Respir Crit Care Med 2009; Feb 1; 179 (03) 241-246.
• 10 Beecroft JM. et al. Pharyngeal narrowing in end-stage renal disease: implications for obstructive sleep apnoea. Eur Respir J 2007; Nov; 30 (05) 965-971.
• 11 Elias RM, Chan CT, Paul N. et al. Relationship of pharyngeal water content and jugular volume with severity of obstructive sleep apnea in renal failure. Nephrol Dial Transplant 2013; Apr; 28 (04) 937-944.
• 12 Tang SC, Lam B, Ku PP. et al. Alleviation of sleep apnea in patients with chronic renal failure by nocturnal cycler-assisted peritoneal dialysis compared with conventional continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 2006; Sep; 17 (09) 2607-2616.
• 13 Beecroft JM, Hoffstein V, Pierratos A. et al. Nocturnal haemodialysis increases pharyngeal size in patients with sleep apnoea and end-stage renal disease. Nephrol Dial Transplant 2008; Feb; 23 (02) 673-679.
• 14 Hanly PJ, Pierratos A. Improvement of sleep apnea in patients with chronic renal failure who undergo nocturnal hemodialysis. N Engl J Med 2001; Jan 11; 344 (02) 102-107.
• 15 Chou YT, Lee PH, Yang CT. et al. Obstructive sleep apnea: a stand-alone risk factor for chronic kidney disease. Nephrol Dial Transplant 2011; Jul; 26 (07) 2244-2250.
• 16 Iseki K. et al. High Prevalence of chronic kidney disease among patients with sleep related breathing disorder (SRBD). Hypertens Res 2008; Feb; 31 (02) 249-255.
• 17 Buchner NJ, Henning BF, Hagele KF. et al. [Renal function in hypertensive patients with obstructive sleep apnea]. Dtsch Med Wochenschr 2004; Feb 13; 129 (07) 305-309.
• 18 Agrawal V, Vanhecke TE, Rai B. et al. Albuminuria and renal function in obese adults evaluated for obstructive sleep apnea. Nephron Clin Pract 2009; 113 (03) c140-7.
• 19 Kanbay A, Buyukoglan H. et al. Obstructive sleep apnea syndrome is related to the progression of chronic kidney disease. Int Urol Nephrol 2013; 44 (02) 535-539.
• 20 Koga S, Ikeda S, Yasunaga T. et al. Effects of nasal continuous positive airway pressure on the glomerular filtration rate in patients with obstructive sleep apnea syndrome. Intern Med 2013; 52 (03) 345-349.
• 21 Fleischmann G, Fillafer G, Matterer H. et al. Prevalence of chronic kidney disease in patients with suspected sleep apnoea. Nephrol Dial Transplant 2010; Jan; 25 (01) 181-186.
• 22 Zhang XB, Lin QC, Deng CS. et al. Elevated serum cystatin C in severe OSA younger men without complications. Sleep Breath 2013; Mar; 17 (01) 235-241.
• 23 Canales MT, Paudel ML, Taylor BC. et al. Sleep-disordered breathing and urinary albumin excretion in older men. Sleep Breath 2011; Jan; 15 (01) 137-144.
• 24 Faulx MD, Storfer-Isser A, Kirchner HL. et al. Obstructive sleep apnea is associated with increased urinary albumin excretion. Sleep 2007; Jul; 30 (07) 923-929.
• 25 Tsioufis C, Thomopoulos C, Dimitriadis K. et al. Association of obstructive sleep apnea with urinary albumin excretion in essential hypertension: a cross-sectional study. Am J Kidney Dis 2008; Aug; 52 (02) 285-293.
• 26 Daskalopoulou EG, Liavvas C, Nakas CT. et al. Obstructive sleep apnoea syndrome promotes reversal albuminuria during sleep. Sleep Breath 2011; Sep; 15 (03) 589-597.
• 27 Varlami V, Malakasioti G, Alexopoulos EI. et al. Low-grade albuminuria in children with obstructive sleep apnea. J Sleep Res 2007; Jun; 22 (03) 289-294.
• 28 Buyukaydin B, Akkoyunlu ME, Kazancioglu R. et al. The effect of sleep apnea syndrome on the development of diabetic nephropathy in patients with type 2 diabetes. Diabetes Res Clin Pract 2012; Oct; 98 (01) 140-143.
• 29 Chaudhary BA. et al. Sleep apnea, proteinuria, and nephrotic syndrome. Sleep 1988; Feb; 11 (01) 69-74.
• 30 Pohl MA. et al. Independent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the irbesartan diabetic nephropathy trial: clinical implications and limitations. J Am Soc Nephrol 2005; Oct; 16 (10) 3027-3037.
• 31 Fletcher EC, Orolinova N, Bader M. Blood pressure response to chronic episodic hypoxia: the renin-angiotensin system. J Appl Physiol 2002; Feb; 92 (02) 627-633.
• 32 Pratt-Ubunama MN, Nishizaka MK, Boedefeld RL. et al. Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension. Chest 2007; Feb; 131 (02) 453-459.
• 33 Greene EL, Kren S, Hostetter TH. Role of aldosterone in the remnant kidney model in the rat. J Clin Invest 1996; Aug 15; 98 (04) 1063-1068.
• 34 Dudenbostel T, Calhoun DA. Resistant hypertension, obstructive sleep apnoea and aldosterone. J Hum Hypertens 2012; May; 26 (05) 281-287.
• 35 Sim JJ, Yan EH, Liu IL. et al. Positive relationship of sleep apnea to hyperaldosteronism in an ethnically diverse population. J Hypertens 2011; Aug; 29 (08) 1553-1559.
• 36 Witkowski A. et al. Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea. Hypertension 2011; Oct; 58 (04) 559-565.
• 37 Svatikova A. et al. Obstructive sleep apnea and aldosterone. Sleep 2009; Dec; 32 (12) 1589-1592.
• 38 Buchner NJ. et al. Microvascular endothelial dysfunction in obstructive sleep apnea is caused by oxidative stress and improved by continuous positive airway pressure therapy. Respiration 2012; 82 (05) 409-417.
• 39 Buchner NJ. et al. The renal resistance index is increased in mild-to-moderate obstructive sleep apnoea and is reduced under continuous positive airway pressure. Nephrol Dial Transplant 2011; Mar; 26 (03) 914-920.
• 40 Kinebuchi S. et al. Short-term use of continuous positive airway pressure ameliorates glomerular hyperfiltration in patients with obstructive sleep apnoea syndrome. Clin Sci (Lond) 2004; Sep; 107 (03) 317-322.
• 41 Serra A, Romero R, Lopez D. et al. Renal injury in the extremely obese patients with normal renal function. Kidney Int 2008; Apr; 73 (08) 947-955.
• 42 Masuda T, Murata M, Honma S. et al. Sleep-disordered breathing predicts cardiovascular events and mortality in hemodialysis patients. Nephrol Dial Transplant 2007; Jul; 26 (07) 2289-2295.
• 43 Kuhlmann U, Hoyer J. Kann man die Progression der chronischen Niereninsuffizienz verzögern?. Internist 2008; 49: 451-464.